.png){kind=icon}
.png){kind=icon}
Return
Efficacy and Hypoglycaemia Outcomes With Once-Weekly IcoSema Versus Comparators in Individuals With Type 2 Diabetes by Kidney and Liver Function: A Post Hoc Analysis of the COMBINE 1–3 Trials
.png){kind=icon}
OA
AI
L
J
M
P
A
S
R
DOI：10.1111/dom.70895.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
This post hoc analysis of COMBINE 1–3 assessed efficacy and hypoglycaemia outcomes with IcoSema (once-weekly combination therapy of basal insulin icodec and semaglutide [a glucagon-like peptide-1 analogue]) versus comparators in adults with type 2 diabetes (T2D) by kidney and liver function subgroups.
Keywords:
basal insulin
fixed-ratio combination
GLP-1 analogue
glycaemic control
hypoglycaemia
type 2 diabetes
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
D
IF:
5.7
Papers:
372
Citations:
0
Organization
Cited Papers